Kynam Capital Management, LP: holdings and changes
Number 60 of the top 100 funds by copy return. Kynam Capital Management, LP reported 34 US stocks worth $1.8B for the quarter ending 2026-09-30 and changed 4 new, 7 added, 5 trimmed and 2 sold since 2026-06-30.
Copy return, 4 quarters+44.2%
US 500, same time+14.5%
Size$1.8B
Stocks34
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| LEGN Legend Biotech Corp | ADD +205% | 10.08% | $182M | 9,154,389 |
| CLDX Celldex Therapeutics INC | TRIM -5% | 9.09% | $164M | 5,066,051 |
| SNDX Syndax Pharmaceuticals INC | 8.48% | $153M | 8,150,959 | |
| PCVX Vaxcyte INC | TRIM -11% | 8.22% | $148M | 2,607,964 |
| VRDN Viridian Therapeutics INC | TRIM -5% | 7.01% | $127M | 6,148,000 |
| COGT Cogent Biosciences INC | ADD +3% | 6.72% | $121M | 3,792,289 |
| TVTX Travere Therapeutics INC | 6.52% | $118M | 2,000,000 | |
| URGN Urogen Pharma LTD | 5.48% | $99M | 2,434,207 | |
| VERA Vera Therapeutics INC | ADD +4% | 5.36% | $97M | 3,000,000 |
| BEAM Beam Therapeutics INC | ADD +38% | 5.33% | $96M | 3,933,894 |
| CTMX Cytomx Therapeutics INC | 3.18% | $58M | 21,140,726 | |
| MBX Mbx Biosciences INC | 3.03% | $55M | 934,799 | |
| SMMT Summit Therapeutics | ADD +150% | 2.81% | $51M | 3,000,000 |
| RLAY Relay Therapeutics INC | TRIM -17% | 2.75% | $50M | 2,751,500 |
| CULLINAN ONCOL Cullinan Oncology INC | 2.65% | $48M | 3,114,132 | |
| IMCR Immunocore Holdings Limited | 2.31% | $42M | 1,375,000 | |
| NRIX Nurix Therapeutics INC | 1.57% | $28M | 1,194,757 | |
| PHVS Pharvaris N V | ADD +25% | 1.45% | $26M | 824,843 |
| BNR Burning Rock Biotech LTD-Adr | 1.21% | $22M | 1,238,563 | |
| BCRX Biocryst Pharmaceuticals INC | 1.16% | $21M | 2,522,660 | |
| SRZN Surrozen INC | BUY | 0.87% | $16M | 486,252 |
| STRO Sutro Biopharma INC | 0.78% | $14M | 872,558 | |
| XENE Xenon Pharmaceuticals INC | BUY | 0.58% | $10M | 280,000 |
| EVMN Evommune INC | BUY | 0.55% | $10M | 1,200,000 |
| PRLD Prelude Therapeutics INC | TRIM -4% | 0.50% | $9M | 2,311,955 |
| GERN Geron Corp | 0.47% | $8M | 6,836,318 | |
| PBLS Parabilis Medicines, INC. | 0.45% | $8M | 250,000 | |
| ALEC Alector INC Com | ADD +13% | 0.44% | $8M | 4,308,494 |
| AMRN Amarin Corp PLC Adr | 0.38% | $7M | 532,982 | |
| IMPRIMIS PHARM Imprimis Pharmaceuticals, INC. | BUY | 0.21% | $4M | 124,655 |
| CRBU Caribou Biosciences INC | 0.18% | $3M | 2,503,302 | |
| PROQR THRAPEUT Proqr Thrapeutics N V | 0.14% | $3M | 1,566,317 | |
| ENGN Engene Therapeut | 0.05% | $900k | 457,855 | |
| TRAW Traws Pharma INC | 0.00% | $100k | 84,400 | |
| INSM Insmed INC. | SELL | 0% | was $11M | 0 |
| CADL Candel Therapeutics INC | SELL | 0% | was $1M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +27.3% | +11.2% |
| 2023-12-31 → 2024-03-31 | +29.0% | +10.0% |
| 2024-03-31 → 2024-06-30 | -2.1% | +4.0% |
| 2024-06-30 → 2024-09-30 | +13.2% | +5.4% |
| 2024-09-30 → 2024-12-31 | -5.0% | +2.1% |
| 2024-12-31 → 2025-03-31 | -17.7% | -4.6% |
| 2025-03-31 → 2025-06-30 | +0.2% | +10.5% |
| 2025-06-30 → 2025-09-30 | +29.5% | +7.8% |
| 2025-09-30 → 2025-12-31 | +41.8% | +2.4% |
| 2025-12-31 → 2026-03-31 | +6.4% | -4.6% |
| 2026-03-31 → 2026-06-30 | +8.4% | +14.8% |
| 2026-06-30 → 2026-09-30 | -11.9% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP